← Back to Search

Behavioural Intervention

Sleep-Focused Lifestyle Support for Postpartum Weight Loss (SGOALS Trial)

N/A
Waitlist Available
Led By Marquis Hawkins, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to help new mothers lose weight by improving their sleep, diet, and physical activity through the Sleep GOALS program. The study will test if this approach is practical and effective.

Who is the study for?
This trial is for new mothers who are 3 to 6 months postpartum, overweight with a BMI over 25, not very active (less than 150 minutes of exercise per week), and have poor sleep according to the RU_SATED questionnaire. They must have a smartphone, internet at home, and be willing to follow the study plan.
What is being tested?
The study tests a new weight loss program called Sleep GOALS that aims to improve sleep, diet, and physical activity. Participants will either receive this intervention or just educational material. The goal is to see if it's feasible, acceptable, and effective in helping lose weight.
What are the potential side effects?
Since this trial involves lifestyle changes rather than medication there may not be traditional side effects; however participants might experience fatigue or stress from adjusting their routines or using new technologies involved in the program.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1 to 16
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1 to 16 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability - Proportion of agreeing
Engagement - Number of modules completed
Engagement - Number of self-monitoring of diet, sleep and physical activity weekly
+5 more
Secondary study objectives
Postpartum weight retention
Weight change

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Sleep GOALSExperimental Treatment1 Intervention
Weekly 15-to-20 minute educational video each, a commercial activity tracker (e.g., Fitbit) to monitor sleep and physical activity, wireless scale to monitor weight, and a lifestyle coach who will provide personalized support.
Group II: EducationActive Control1 Intervention
Brochures that provide tips for improving sleep health, diet, and physical activity

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common weight loss treatments, particularly those focusing on behavioral modifications like improving sleep, diet, and physical activity, work through several mechanisms. Improved sleep helps regulate hunger and satiety hormones, reducing overeating. Dietary changes reduce caloric intake and improve nutrition, aiding in weight management. Increased physical activity boosts energy expenditure and metabolic rate. These combined strategies create a caloric deficit, enhance metabolic function, and improve overall health, making them effective and sustainable for weight loss patients.
Mindfulness and Behavior Change.Treatment of compulsive exercise in eating disorders and muscle dysmorphia: protocol for a systematic review.A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Evaluating the Evidence Base of Melatonin, Light Exposure, Exercise, and Complementary and Alternative Medicine for Patients with Insomnia Disorder.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,792 Previous Clinical Trials
16,359,946 Total Patients Enrolled
61 Trials studying Obesity
14,319 Patients Enrolled for Obesity
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,943 Previous Clinical Trials
47,797,853 Total Patients Enrolled
256 Trials studying Obesity
211,676 Patients Enrolled for Obesity
Marquis Hawkins, PhDPrincipal InvestigatorUniversity of Pittsburgh

Media Library

Education (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05942326 — N/A
Obesity Research Study Groups: Education, Sleep GOALS
Obesity Clinical Trial 2023: Education Highlights & Side Effects. Trial Name: NCT05942326 — N/A
Education (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05942326 — N/A
~18 spots leftby Dec 2025